China Isotope & Radiation Corporation (1763.HK)

HKD 10.4

(-2.07%)

Operating Income Summary of China Isotope & Radiation Corporation

  • China Isotope & Radiation Corporation's latest annual operating income in 2023 was 941.59 Million CNY , up 7.78% from previous year.
  • China Isotope & Radiation Corporation's latest quarterly operating income in 2024 Q2 was 409.42 Million CNY , down 0.0% from previous quarter.
  • China Isotope & Radiation Corporation reported an annual operating income of 873.66 Million CNY in 2022, up 17.61% from previous year.
  • China Isotope & Radiation Corporation reported an annual operating income of 742.85 Million CNY in 2021, up 27.96% from previous year.
  • China Isotope & Radiation Corporation reported a quarterly operating income of 941.59 Million CNY for 2023 FY, up 7.78% from previous quarter.
  • China Isotope & Radiation Corporation reported a quarterly operating income of 600.82 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of China Isotope & Radiation Corporation (2023 - 2015)

Historical Annual Operating Income of China Isotope & Radiation Corporation (2023 - 2015)

Year Operating Income Operating Income Growth
2023 941.59 Million CNY 7.78%
2022 873.66 Million CNY 17.61%
2021 742.85 Million CNY 27.96%
2020 580.55 Million CNY -13.35%
2019 670 Million CNY -0.98%
2018 676.65 Million CNY 27.66%
2017 530.05 Million CNY 6.36%
2016 498.36 Million CNY 7.73%
2015 462.6 Million CNY 0.0%

Peer Operating Income Comparison of China Isotope & Radiation Corporation

Name Operating Income Operating Income Difference
Vincent Medical Holdings Limited 65.78 Million HKD -1331.435%